Table 1.

Effect of resveratrol and longevinex on myocardial function.

	Control	Resveratrol	Longevinex
Coronary flow (mL/min)
Baseline	24 ± 2.1	25 ± 3.0	24 ± 2.4
60 min rep.	22 ± 2.3	24 ± 2.5	23 ± 3.1
120 min rep.	23 ± 2.0	24 ± 2.8	25 ± 1.9
Aortic flow (mL/min)
Baseline	51 ± 2.3	53 ± 4.0	52 ± 3.8
60 min rep.	25 ± 3.2	35 ± 3.7	38 ± 2.7
120 min rep.	8.5 ± 2.7	24 ± 3.2	26 ± 3.5
LVDP (mm Hg)
Baseline	116 ± 6	117 ± 7	119 ± 9
60 min rep.	80 ± 5	98 ± 5	101 ± 6
120 min rep.	54 ± 7	84 ± 7	86 ± 5
LVmaxdp/dt (mm Hg/sec)
Baseline	3056 ± 48	1845 ± 45	1028 ± 56
60 min rep.	1689 ± 65	2356 ± 33	1754 ± 39
120 min rep.	1206 ± 38	1877 ± 62	2012 ± 32
Infarct size (infarct area/area of risk)
Baseline	3 ± 2	2.8 ± 1.2	2.1 ± 0.8
120 min rep.	36 ± 4	19 ± 3	17 ± 2
Apoptosis (%)
Baseline	1 ± 1	1 ± 0.8	1 ± 0.7
120 min rep.	22 ± 3	9 ± 2	8 ± 2